Nature Search

Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?

H Gogas
FJ Lofts
JL Mansi
Research01 Jan 1998
British Journal of Cancer

Volume: 77, P: 325-328
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group

D Bafaloukos
C Papadimitriou
A M Dimopoulos
ResearchOpen Access19 Oct 2004
British Journal of Cancer

Volume: 91, P: 1639-1644
Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer

H Gogas
FJ Lofts
JL Mansi
Research01 Sept 1997
British Journal of Cancer

Volume: 76, P: 639-642
Reply: Value of tyrosinase RT–PCR in melanoma prognosis

H Gogas
CorrespondenceOpen Access18 Mar 2003
British Journal of Cancer

Volume: 88, P: 982
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

Meta-analysis of 36,760 cases and 375,188 controls identifies 54 loci associated with susceptibility to cutaneous melanoma. Further analysis combining nevus count and hair color GWAS results provide insights into the genetic architecture of melanoma.

Maria Teresa Landi
D. Timothy Bishop
Matthew H. Law
Research27 Apr 2020
Nature Genetics

Volume: 52, P: 494-504
Prognostic significance of the sequential detection of circulating melanoma cells by RT–PCR in high-risk melanoma patients receiving adjuvant interferon

H Gogas
G Kefala
D Loukopoulos
ResearchOpen Access09 Jul 2002
British Journal of Cancer

Volume: 87, P: 181-186
Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer

U Halm
T Schumann
V Keim
ResearchOpen Access03 Feb 2000
British Journal of Cancer

Volume: 82, P: 1013-1016
Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

C Ziske
C Schlie
I G H Schmidt-Wolf
ResearchOpen Access14 Oct 2003
British Journal of Cancer

Volume: 89, P: 1413-1417
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab

Helen Gogas
Shruthi Ravimohan
Céleste Lebbé
ResearchOpen Access19 Jul 2024
npj Precision Oncology

Volume: 8, P: 1-13
A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

T R J Evans
K W Colston
J L Mansi
ResearchOpen Access26 Feb 2002
British Journal of Cancer

Volume: 86, P: 680-685
Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases

S Armaou
M Pertesi
I Konstantopoulou
ResearchOpen Access02 Jun 2009
British Journal of Cancer

Volume: 101, P: 32-37
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

A K Koutras
K T Kalogeras
G Fountzilas
ResearchOpen Access04 Nov 2008
British Journal of Cancer

Volume: 99, P: 1775-1785

Search

Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?

Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group

Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer

Reply: Value of tyrosinase RT–PCR in melanoma prognosis

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

Prognostic significance of the sequential detection of circulating melanoma cells by RT–PCR in high-risk melanoma patients receiving adjuvant interferon

Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

Search

Quick links

Search

Filter By:

Search

Quick links